WAKU reports ¥480 million in total pre-Series A funding
The agritech company combines a commercial glutathione crop biostimulant with research into yeast-based production of functional materials.
Crop stress support and biomanufacturing research
WAKU's WAKUFUL uses glutathione to support plants' response to heat, drought and other environmental stresses and is already commercialized. The company is also researching fission yeast as a platform to produce glutathione and other functional materials. In August 2026, it completed ¥150 million in equity financing and ¥150 million in lending, following a ¥180 million equity raise in July 2025.
Use of funds
Scale WAKUFUL sales, manufacturing, distribution and overseas business
Advance fission-yeast R&D and high-function material production